Ignite Creation Date:
2025-12-24 @ 12:49 PM
Ignite Modification Date:
2025-12-27 @ 9:11 PM
Study NCT ID:
NCT05613361
Status:
UNKNOWN
Last Update Posted:
2023-10-31
First Post:
2022-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effect of Curcumin Against Colistin-induced Nephrotoxicity
Sponsor:
October 6 University
Organization:
Study Overview
Official Title:
The Effect of Curcumin Against Colistin-induced Nephrotoxicity
Status:
UNKNOWN
Status Verified Date:
2023-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to investigate the possible nephroprotective effect of curcumin in critically ill patients receiving colistin.
Detailed Description:
The study will investigate the possible nephroprotective effect of curcumin when added to patients infected by MDR Gram-negative bacteria and require intravenous colistin therapy, curcumin will be given concurrently with colistin and discontinued at the same time as Colistin.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: